U.S. drugmaker Merck & Co said on Wednesday it has sold its equity investment in Moderna Inc, after benefiting from a surge in the stock price of the vaccine developer this year.
Drugmaker Merck divests stake in vaccine-maker Moderna
- Advertisement -
Most Popular
Bank of Japan keeps rates steady, cuts growth forecasts
Markets are closely watching Ueda’s post-meeting news conference for clues on how US President Donald Trump’s tariffs would affect the BOJ’s rate-hike...
